Kanwal Qudsia, Ahmed Mahmood, Hamza Muhammad, Ahmad Muhammad, Yousaf Numan, Javaid Arshad, Anwar Aneela, Khan Iqra Haider, Muddassar Muhammad
Department of Chemistry, The University of Lahore Lahore Pakistan
Department of Chemistry, Division of Science and Technology, University of Education, College Road Lahore Pakistan
RSC Adv. 2023 Jul 24;13(32):22268-22280. doi: 10.1039/d3ra01432k. eCollection 2023 Jul 19.
Curcumin is an extensively studied natural compound due to its extensive biological applications. However, there are some drawbacks linked to this compound such as poor absorption, low water-solubility, quick systemic elimination, fast metabolism, poor pharmacokinetics, low bioavailability, low penetration targeting efficacy and low stability. To overcome these drawbacks, curcumin is encapsulated in nano-carriers. In the current studies, we synthesized nanoparticles of curcumin without using nanocarriers by different methods such as nano-suspension (Cur-NSM), sonication (Cur-SM) and anti-solvent precipitation (Cur-ASP) to enhance the solubility of curcumin in water. The prepared nanoparticles were characterized by FTIR, SEM and XRD analysis. These curcumin nanoparticles were screened for their solubilities in water, DPPH scavenging, amylase, α-glucosidase and β-glucosidase enzymatic activities. The particle size of nano-curcumin was found to be in the 47.4-98.7 nm range. The reduction in particle size of curcumin dramatically increases its solubility in water to 79.2 μg mL, whereas the solubility of curcumin is just 0.98 μg mL. Cur-ASP showed the highest free radical scavenging potential (48.84 ± 0.98%) which was comparable with standard BHT (50.48 ± 1.11%) at 75.0 μg mL. As well, Cur-ASP showed the highest inhibition of α-amylase (68.67 ± 1.02%), α-glucosidase (58.30 ± 0.52%), and β-glucosidase (64.80 ± 0.43%) at 100 μg mL which is comparable with standard drug acarbose. The greater surface area of nanoparticles exposes the various groups of curcumin for blocking the binding sites of enzymes. This strategy may be helpful in designing curcumin as a potent therapeutic agent against diabetes mellitus. Further, the molecular interactions of curcumin with α-amylase, α-glucosidase, β-glucosidase, and polyphenol oxidase were assessed by analyzing the plausible binding modes of curcumin in the binding pocket of each receptor. The best binding mode of curcumin was used to make complexes with the target proteins and their stability was confirmed by 50 ns MD simulation.
姜黄素是一种因具有广泛生物学应用而被广泛研究的天然化合物。然而,这种化合物存在一些缺点,如吸收差、水溶性低、全身快速清除、代谢快、药代动力学不佳、生物利用度低、靶向穿透效果差以及稳定性低。为克服这些缺点,姜黄素被封装在纳米载体中。在当前研究中,我们通过不同方法,如纳米悬浮法(Cur - NSM)、超声法(Cur - SM)和反溶剂沉淀法(Cur - ASP),在不使用纳米载体的情况下合成了姜黄素纳米颗粒,以提高姜黄素在水中的溶解度。通过傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)和X射线衍射(XRD)分析对制备的纳米颗粒进行了表征。对这些姜黄素纳米颗粒进行了在水中的溶解度、二苯基苦味酰基自由基(DPPH)清除能力、淀粉酶、α - 葡萄糖苷酶和β - 葡萄糖苷酶活性的筛选。发现纳米姜黄素的粒径在47.4 - 98.7纳米范围内。姜黄素粒径的减小显著提高了其在水中的溶解度至79.2μg/mL,而姜黄素的溶解度仅为0.98μg/mL。在75.0μg/mL时,Cur - ASP表现出最高的自由基清除潜力(48.84±0.98%),与标准丁基羟基甲苯(BHT,50.48±1.11%)相当。同样,在100μg/mL时,Cur - ASP对α - 淀粉酶(68.67±1.02%)、α - 葡萄糖苷酶(58.30±0.52%)和β - 葡萄糖苷酶(64.80±0.43%)的抑制作用最强,与标准药物阿卡波糖相当。纳米颗粒更大的表面积使姜黄素的各种基团暴露出来,从而阻断酶的结合位点。这种策略可能有助于将姜黄素设计成一种有效的抗糖尿病治疗剂。此外,通过分析姜黄素在每个受体结合口袋中的合理结合模式,评估了姜黄素与α - 淀粉酶、α - 葡萄糖苷酶、β - 葡萄糖苷酶和多酚氧化酶的分子相互作用。使用姜黄素的最佳结合模式与靶蛋白形成复合物,并通过50纳秒的分子动力学(MD)模拟确认了它们的稳定性。
Int J Nanomedicine. 2012-7-27
ACS Omega. 2021-3-18
Int J Biol Macromol. 2020-1-23
Cell Biochem Biophys. 2025-6-17
Front Pharmacol. 2025-3-17
Spectrochim Acta A Mol Biomol Spectrosc. 2023-1-15
ACS Omega. 2021-3-18
Front Bioeng Biotechnol. 2020-10-15
Antioxidants (Basel). 2020-11-6
J Chem Phys. 2020-7-28